Niox Group plc (NIOX) ORD GBP0.0008
Sell:69.40pBuy:71.00p
2.40p
(3.36%)
0.29%- This stock can be held in a
Create an alert
Stocks and Shares ISA2.40p
(3.36%)2.40p
(3.36%)Company Information
About this company
NIOX Group plc is a United Kingdom-based diagnostics and management company. The Company is engaged in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNO), a precise biomarker for asthma. The Company's NIOX VERO is also the device of choice by clinical research organizations for respiratory studies. The device is used by healthcare professionals to improve asthma care, which assists diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance, and reducing the likelihood of exacerbations in at-risk patients compared to traditional monitoring. The Company provides products and services via its direct sales organization and extensive distributor network in over 50 countries.
Key people
Key facts
- EPICNIOX
- LocationUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINGB00BJVD3B28
- Market cap£288.27m
- Employees84
- Shares in issue417.78m
- ExchangeLondon Stock Exchange (LON)
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.